References
- Rosenzweig SD, Uzel G, Holland SM. Phagocyte disorders. Immunologic Disorders in Infant and Children5th edn, Stiehm, Ochs, Winkelstein. Elsevier Saunders, Philadelphia 2004; 618–651
- Pitt JI. The current role of Aspergillus and Penicillium in human and animal health. J Med Vet Mycol 1994; 32(Suppl. 1)17–32
- Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994; 344: 110–113
- Pitt JI. The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces. Academic Press, London 1979
- White T J, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA sequences for phylogenetics. PCR Protocols: A Guide to Methods and Applications, MA Innis, DH Gefland, JJ Sninsky, TJ White. Academic Press, Inc, New York 1990; 315–322
- Horré R, Gilges S, Breig P, et al. Case Report. Fungaemia due to Penicillium piceum, a member of the Penicillium marneffei complex. Mycoses 2001; 44: 502–504
- Lyratzopoulos G, Ellis M, Nerringer R, Denning DW. Invasive infection due to Penicillium species other than P. marneffei. J Infec 2002; 45: 184–207
- Margolis DM, Melnik DA, Alling DW, Gallin JI. Trimetropim-sulfamethozasole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 1990; 162: 723–726
- The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991; 324: 509–516.
- Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 369 patients. Medicine 2000; 79: 155–169
- Gallin J.i, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003; 348: 2416–2422
- Hassett DJ, Cohen MS. Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J 1989; 3: 2574–2582
- Eremin AN, Metelitsa DI, Moroz IV, Pavlovskaia ZhI, Mikhailova RV. Kinetic characteristics of extracellular catalase from Penicillium piceum F-648 and variants of fungi, adapted to hydrogen peroxide. Prikl Biokhim Mikrobiol 2002; 38: 374–380
- Pavlovskaia ZhI, Mikhailova RV, Moroz IV, Eremin AN. Resistance of Penicillium piceum F-648 to hydrogen peroxide under short term and prolonged oxidative stress. Prikl Biokhim Mikrobiol 2003; 39: 31–36
- Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical and clinical features of chronic granulomatous disease. Medicine 2000; 79: 170–200
- Cohen MS, Isturiz RE, Malech HL, Root RK. Fungal infection in chronic granulomatous disease. The importance of the phagocyte defense against fungi. Am J Med 1981; 71: 59–66
- Hall L, Wohfiel S, Roberts GD. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory. J Clin Microbiol 2004; 42: 622–626
- Segal BH, DeCarlo ES, Kwon-Chong KJ, et al. Aspergillus nidulans infection in chronic granulomatous disease. Medicine 1998; 77: 345–354